DNAtrix Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:DNAtrix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11179
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DNAtrix Inc (DNAtrix) is an independent clinical stage, biotechnology company that focuses on the development of oncolytic immunotherapies for cancer. The company’s portfolio of pipeline products includes DNX-2401, a modified common cold virus that targets and kills cancer cells selectively; DNX-2440; DNX-2450; and MYX-135. Its pipeline includes viruses armed with potent immunomodulatory molecules to treat cancer. DNAtrix offer products for the treatment of solid tumors, hematological malignancies, and recurrent glioblastoma among others. The company is funded by Morningside Ventures and Mercury Fund, and Cancer Prevention and Research Institute of Texas. It has offices in Texas and California. DNAtrix is headquartered in Houston, Texas, the US.

DNAtrix Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DNAtrix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
DNAtrix Inc, Medical Devices Deals, 2012 to YTD 2018 9
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
DNAtrix Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
DNAtrix Raises USD15.5 Million in Venture Financing 11
DNAtrix Raises USD20 Million in Series B Financing 12
DNAtrix Raises US$1.5 Million In Venture Financing 13
DNAtrix Secures USD0.84 Million Funding from Mercury Fund 14
DNAtrix Secures USD0.16 Million in Venture Funding 15
DNAtrix Raises US$0.88 Million In Venture Financing 16
DNAtrix Secures USD4.5 Million in Venture Funding 17
Partnerships 18
DNAtrix and Valo Therapeutics Enter into Agreement 18
Merck Enters into Agreement with DNAtrix 19
Merger 20
DNAtrix Merges With VectorLogics 20
Licensing Agreements 21
DNAtrix Enters into Licensing Agreement with University of Florida 21
DNAtrix Inc – Key Competitors 22
DNAtrix Inc – Key Employees 23
DNAtrix Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Product News 25
11/20/2017: Mechanism of Action Studies for DNAtrix’s Oncolytic Virus DNX-2401 Presented at the 2017 Society for Neuro-Oncology Annual Meeting 25
11/13/2017: DNAtrix Virus Expressing T-Cell Co-stimulator OX40L (CD252) Presented at the 2017 Society for Immunotherapy of Cancer Meeting 26
Clinical Trials 27
Jun 01, 2017: DNAtrix to Present Results of DNX-2401 for Recurrent Glioblastoma at ASCO 2017 27
Apr 24, 2017: Precision Intratumoral Delivery of DNX-2401 with the Alcyone MEMS Cannula 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
DNAtrix Inc, Pharmaceuticals & Healthcare, Key Facts 2
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DNAtrix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DNAtrix Inc, Deals By Therapy Area, 2012 to YTD 2018 8
DNAtrix Inc, Medical Devices Deals, 2012 to YTD 2018 9
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
DNAtrix Raises USD15.5 Million in Venture Financing 11
DNAtrix Raises USD20 Million in Series B Financing 12
DNAtrix Raises US$1.5 Million In Venture Financing 13
DNAtrix Secures USD0.84 Million Funding from Mercury Fund 14
DNAtrix Secures USD0.16 Million in Venture Funding 15
DNAtrix Raises US$0.88 Million In Venture Financing 16
DNAtrix Secures USD4.5 Million in Venture Funding 17
DNAtrix and Valo Therapeutics Enter into Agreement 18
Merck Enters into Agreement with DNAtrix 19
DNAtrix Merges With VectorLogics 20
DNAtrix Enters into Licensing Agreement with University of Florida 21
DNAtrix Inc, Key Competitors 22
DNAtrix Inc, Key Employees 23

List of Figures
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DNAtrix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
DNAtrix Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[DNAtrix Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Schroders Plc
    Schroders Plc - Strategy, SWOT and Corporate Finance Report Summary Schroders Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Biocurv Medical Instruments, Inc.:企業の戦略・SWOT・財務分析
    Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report Summary Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Starpharma Holdings Ltd (SPL):企業の財務・戦略的SWOT分析
    Starpharma Holdings Ltd (SPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • McDonald’s Australia Limited:企業の戦略的SWOT分析
    McDonald's Australia Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • EndoGastric Solutions Inc:医療機器:M&Aディール及び事業提携情報
    Summary EndoGastric Solutions Inc (EGS), formerly EsophyX Inc, is a medical device company that manufactures and markets gastroenterology and surgical products for the treatment of gastroesophageal reflux disease (GERD). The company’s products comprise esophyX device and Serosa-Fuse fasteners. Its t …
  • Expro Holdings UK 3 Ltd:企業の戦略的SWOT分析
    Expro Holdings UK 3 Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • White Mountains Insurance Group Ltd:企業のM&A・事業提携・投資動向
    White Mountains Insurance Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's White Mountains Insurance Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • China Railway Signal & Communication Corp Ltd:企業の戦略・SWOT・財務情報
    China Railway Signal & Communication Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary China Railway Signal & Communication Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Evertec Inc (EVTC):企業の財務・戦略的SWOT分析
    Summary Evertec Inc (Evertec) is a technology and communication company that offers transaction processing services. The company’s services include payment processing, merchant acquiring and business process management. Its payment processing services comprise card issuing and acquiring processing; …
  • Transocean Ltd.:企業の戦略・SWOT・財務情報
    Transocean Ltd. - Strategy, SWOT and Corporate Finance Report Summary Transocean Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Berkshire Hathaway Energy Co:企業の戦略的SWOT分析
    Berkshire Hathaway Energy Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Calfrac Well Services Ltd (CFW):企業の財務・戦略的SWOT分析
    Calfrac Well Services Ltd (CFW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • GenSight Biologics SA (SIGHT):製薬・医療:M&Aディール及び事業提携情報
    Summary GenSight Biologics SA (GenSight) is a clinical stage biotechnology company that discovers and develops novel therapies for mitochondrial and neurodegenerative diseases. The company’s product pipeline comprises GS010 and GS030 developed for the treatment of retinal degenerative diseases. It d …
  • San Miguel Brewery Hong Kong Ltd.
    San Miguel Brewery Hong Kong Ltd. - Strategy, SWOT and Corporate Finance Report Summary San Miguel Brewery Hong Kong Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • CMP Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CMP Pharma Inc (CMP Pharma), formerly Carolina Medical Products Company Inc is a specialty pharmaceutical company that develops and manufactures generic prescription, non-prescription and skin care products. The company’s prescription products include SPS suspension, isoniazid oral solution …
  • Westrock Company:企業の戦略・SWOT・財務情報
    Westrock Company - Strategy, SWOT and Corporate Finance Report Summary Westrock Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Provectus Biopharmaceuticals Inc (PVCT):企業の財務・戦略的SWOT分析
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Surge Global Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Surge Global Energy Inc (Surge Global) is an independent oil and gas exploration, production and trading company. The company acquires, finance and develops oil and gas properties. Its energy and metal commodities comprise natural gas, crude oil, coal, electricity, refined petroleum products …
  • Schott AG:企業の戦略的SWOT分析
    Schott AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • The Northwestern Mutual Life Insurance Company:戦略・SWOT・企業財務分析
    The Northwestern Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary The Northwestern Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆